| Physical Performance under Family Welfare Programme in Alipurduar District of West Bengal (2020-2021) | ||||||||||
| (In Number) | ||||||||||
| Particulars | Alipurduar | West Bengal | ||||||||
| Total | Urban | Rural | Public | Private | Total | Urban | Rural | Public | Private | |
| Ante Natal Care (ANC) | ||||||||||
| Total Number of Pregnant Women Registered for Ante Natal Care (ANC) | ||||||||||
| Out of the Total ANC Registered, Number Registered within 1st Trimester (Within 12 Weeks) | ||||||||||
| Number of PW given TT1/ Td1 | ||||||||||
| Number of PW given TT2 / Td2 | ||||||||||
| Number of PW given TT Booster/ Td Booster | ||||||||||
| Number of PW Provided Full Course 180 Iron Folic Acid (IFA) Tablets | ||||||||||
| Number of PW Provided Full Course 180 Iron Folic Acid (IFA) Tablets | ||||||||||
| Number of PW given one Albendazole tablet after 1st Trimester | ||||||||||
| Number of PW Received 4 or more ANC Check ups | ||||||||||
| Number of PW given ANC Corticosteroids in Pre Term Labour | ||||||||||
| New Cases of PW with Hypertension Detected | ||||||||||
| Out of the New Cases of PW with Hypertension Detected, Cases Managed at Institution | ||||||||||
| Number of Eclampsia Cases managed during Delivery | ||||||||||
| Number of PW Tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs | ||||||||||
| Number of PW Having Hb level<11 (out of Total Tested Cases)(7.1 to 10.9) | ||||||||||
| Number of PW Having Hb level<7 (out of Total Tested Cases) | ||||||||||
| Number of PW Having severe anaemia (Hb < 7) treated | ||||||||||
| Number of PW Tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test) | ||||||||||
| Number of PW Tested Positive for GDM | ||||||||||
| Number of PW given insulin out of Total Tested Positive for GDM | ||||||||||
| Number of PW Tested using POC Test for Syphilis | ||||||||||
| Out of Above, Number of PW Found Sero Positive for Syphilis | ||||||||||
| Number of Pregnant Women Tested for Syphilis | ||||||||||
| Number of Pregnant Women Tested Found Sero Positive for Syphilis | ||||||||||
| Number of Syphilis Positive pregnanat Women treated for Syphilis | ||||||||||
| Number of Babies daignosed with Congenital Syphilis | ||||||||||
| Number of Babies treated for Congenital Syphilis | ||||||||||
| Deliveries | ||||||||||
| Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM/ Midwife) | ||||||||||
| Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.) | ||||||||||
| Number of PW given Tablet Misoprostol during home Delivery | ||||||||||
| Number of Newborns Received 7 Home Based Newborn Care (HBNC) Visits in case of Home Delivery | ||||||||||
| Number of Institutional Deliveries Conducted (Including C-Sections) | ||||||||||
| Out of Total institutional Deliveries Number of Women Discharged within 48 hours of Delivery | ||||||||||
| Number of Newborns Received 6 HBNC Visits after Institutional Delivery | ||||||||||
| Number of Caesarean (C-Section) Deliveries | ||||||||||
| Total C - Section Deliveries performed | ||||||||||
| C-sections, performed at night (8 PM- 8 AM) | ||||||||||
| Pregnancy Outcome and Details of New-Born | ||||||||||
| Live Birth - Male | ||||||||||
| Live Birth - Female | ||||||||||
| Number of Pre term Newborns (< 37 weeks of Pregnancy) | ||||||||||
| Still Birth | ||||||||||
| Abortion (spontaneous) | ||||||||||
| MTP up to 12 weeks of Pregnancy | ||||||||||
| MTP more than 12 weeks of Pregnancy | ||||||||||
| Post Abortion/ MTP Complications Identified | ||||||||||
| Post Abortion/ MTP Complications Treated | ||||||||||
| Number of Women Provided with Post abortion/ MTP contraception | ||||||||||
| Number of Newborns weighed at birth | ||||||||||
| Number of Newborns Having weight less than 2.5 kg | ||||||||||
| Number of Newborns breast fed within 1 hour of birth | ||||||||||
| Complicated Pregnancies | ||||||||||
| Number of Cases of Pregnant Women with Obstetric Complications attended (Antepartum haemorrhage (APH), Post-Partum Hemorrhage (PPH), Sepsis, Eclampsia and others) | ||||||||||
| Number of Complicated pregnancies treated with Blood Transfusion | ||||||||||
| Post Natal Care (PNC) | ||||||||||
| Women Receiving 1st Post partum Checkups within 48 hours of home Delivery | ||||||||||
| Women Receiving 1st Post partum Checkup between 48 hours and 14 days | ||||||||||
| Number of Mothers Provided full course of 180 IFA Tablets after Delivery | ||||||||||
| Number of Mothers Provided full course of 360 Calcium Tablets after Delivery | ||||||||||
| Reproductive Tract Infections/Sexually Transmitted Infections (RTI/STI) Cases | ||||||||||
| New RTI/STI Cases Identified - Male | ||||||||||
| New RTI/STI Cases Identified - Female | ||||||||||
| RTI/STI for which Treatment initiated - Male | ||||||||||
| RTI/STI for which Treatment initiated - Female | ||||||||||
| Family Planning | ||||||||||
| Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy Conducted | ||||||||||
| Number of Laparoscopic Sterilizations (excluding Post abortion) Conducted | ||||||||||
| Number of Interval Mini-lap (other than Post-partum and Post abortion) Sterilizations Conducted | ||||||||||
| Number of Postpartum Sterilizations (within 7 days of Delivery by minilap or concurrent with caesarean section) Conducted | ||||||||||
| Number of Post Abortion Sterilizations (within 7 days of spontaneous or surgical abortion) Conducted | ||||||||||
| Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD) | ||||||||||
| Number of Postpartum (within 48 hours of Delivery) IUCD insertions | ||||||||||
| Number of Post Abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions | ||||||||||
| Number of IUCD Removals | ||||||||||
| Number of complications Following IUCD Insertion | ||||||||||
| Injectable Contraceptive-Antara Program- First Dose | ||||||||||
| Injectable Contraceptive-Antara Program- Second Dose | ||||||||||
| Injectable Contraceptive-Antara Program- Third Dose | ||||||||||
| Injectable Contraceptive-Antara Program- Fourth or more than fourth | ||||||||||
| Number of Combined Oral Pill cycles distributed | ||||||||||
| Number of Condom pieces distributed | ||||||||||
| Number of Centchroman (weekly) Pill strips distributed | ||||||||||
| Number of Emergency Contraceptive Pills (ECP) given | ||||||||||
| Number of Pregnancy Test Kits (PTK) used | ||||||||||
| Complications Following Male Sterilization | ||||||||||
| Complications Following Female Sterilization | ||||||||||
| Failures Following Male Sterilization | ||||||||||
| Failures Following Female Sterilization | ||||||||||
| Deaths Following Male Sterilization | ||||||||||
| Deaths Following Female Sterilization | ||||||||||
| Child Immunisation | ||||||||||
| Child Immunisation - Vitamin K (Birth Dose) | ||||||||||
| Child Immunisation - BCG | ||||||||||
| Child Immunisation - DPT1 | ||||||||||
| Child Immunisation - DPT2 | ||||||||||
| Child Immunisation - DPT3 | ||||||||||
| Child Immunisation - Pentavalent 1 | ||||||||||
| Child Immunisation - Pentavalent 2 | ||||||||||
| Child Immunisation - Pentavalent 3 | ||||||||||
| Child Immunisation - OPV 0 (Birth Dose) | ||||||||||
| Child Immunisation - OPV1 | ||||||||||
| Child Immunisation - OPV2 | ||||||||||
| Child Immunisation - OPV3 | ||||||||||
| Child Immunisation - Hepatitis-B0 (Birth Dose) | ||||||||||
| Child Immunisation - Hepatitis-B1 | ||||||||||
| Child Immunisation - Hepatitis-B2 | ||||||||||
| Child Immunisation - Hepatitis-B3 | ||||||||||
| Child Immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1) | ||||||||||
| Child Immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) | ||||||||||
| Child Immunisation - Rotavirus 1 | ||||||||||
| Child Immunisation - Rotavirus 2 | ||||||||||
| Child Immunisation - Rotavirus 3 | ||||||||||
| Child Immunisation- PCV 1 | ||||||||||
| Child Immunisation- PCV 2 | ||||||||||
| Child Immunisation- PCV Booster | ||||||||||
| Child Immunisation (9-11months) - Measles & Rubella (MR)/ Measles Containing Vaccine(MCV) - 1st Dose | ||||||||||
| Child Immunisation (9-11months) - Measles 1st dose | ||||||||||
| Child Immunisation (9-11months) - JE 1st dose | ||||||||||
| Children aged between 9 and 11 months fully immunized - Male | ||||||||||
| Children aged between 9 and 11 months fully immunized - Female | ||||||||||
| Child Immunisation(after 12 months) - Measles & Rubella (MR)/Measles Containing Vaccine(MCV)- 1st Dose | ||||||||||
| Child Immunisation (after 12 months) - Measles-1st dose | ||||||||||
| Child Immunisation (after 12 months) - JE 1st dose | ||||||||||
| Child Immunisation - Measles & Rubella (MR)- 2nd Dose (16-24 months) | ||||||||||
| Child Immunisation - Measles 2nd dose (More than 16 months) | ||||||||||
| Child Immunisation - DPT 1st Booster | ||||||||||
| Child Immunisation - OPV Booster | ||||||||||
| Child Immunisation - Measles, Mumps, Rubella (MMR) Vaccine | ||||||||||
| Number of Children more than 16 months of age who Received Japanese Encephalitis (JE) Vaccine | ||||||||||
| Child Immunisation - Typhoid | ||||||||||
| Children more than 5 years Received DPT5 (2nd Booster) | ||||||||||
| Children more than 10 years Received TT10/ Td10 | ||||||||||
| Children more than 16 years Received TT16/ Td16 | ||||||||||
| Number of Cases of AEFI - Abscess | ||||||||||
| Number of Cases of AEFI - Death | ||||||||||
| Number of Cases of AEFI - Others | ||||||||||
| Immunisation sessions planned | ||||||||||
| Immunisation sessions held | ||||||||||
| Number of Immunisation sessions where ASHAs were present | ||||||||||
| Child Immunisation - Vitamin A Dose - 1 | ||||||||||
| Child Immunisation - Vitamin A Dose - 5 | ||||||||||
| Child Immunisation - Vitamin A Dose - 9 | ||||||||||
| Number of Children (6-59 months) Provided 8-10 doses (1ml) of IFA syrup (Bi weekly) | ||||||||||
| Number of Children (12-59 months) Provided Albendazole | ||||||||||
| Number of severely underweight Children Provided Health Checkup (0-5 years) | ||||||||||
| Number of Cases of Childhood Diseases (0-5 years) | ||||||||||
| Childhood Diseases - Pneumonia | ||||||||||
| Childhood Diseases - Asthma | ||||||||||
| Childhood Diseases - Sepsis | ||||||||||
| Childhood Diseases - Diphtheria | ||||||||||
| Childhood Diseases - Pertussis | ||||||||||
| Childhood Diseases - Tetanus Neonatorum | ||||||||||
| Childhood Diseases - Tuberculosis (TB) | ||||||||||
| Childhood Diseases - Acute Flaccid Paralysis(AFP) | ||||||||||
| Childhood Diseases - Measles | ||||||||||
| Childhood Diseases - Malaria | ||||||||||
| Childhood Diseases - Diarrhoea | ||||||||||
| Childhood Diseases - Diarrhoea treated in Inpatients | ||||||||||
| Children Admitted with Respiratory Infections | ||||||||||
| Childhood Diseases - Severe Acute Malnutrition (SAM) | ||||||||||
| National Vector Borne Disease Control Programme (NVBDCP) | ||||||||||
| Total Blood Smears Examined for Malaria | ||||||||||
| Malaria (Microscopy Tests ) - Plasmodium Vivax Test Positive | ||||||||||
| Malaria (Microscopy Tests ) - Plasmodium Falciparum Test Positive | ||||||||||
| RDT Conducted for Malaria | ||||||||||
| Malaria (RDT) - Plasmodium Vivax Test Positive | ||||||||||
| Malaria (RDT) - Plamodium Falciparum Test Positive | ||||||||||
| Kala Azar (RDT) - Tests Conducted | ||||||||||
| Kala Azar Positive Cases | ||||||||||
| Post-kala-azar dermal leishmaniasis (PKDL) Cases | ||||||||||
| Dengue - RDT Test Positive | ||||||||||
| Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) Test Positive | ||||||||||
| Tests Conducted for JE | ||||||||||
| Tests Positive for JE | ||||||||||
| Adolescent Health | ||||||||||
| Girls Registered in AFHC | ||||||||||
| Boys Registered in AFHC | ||||||||||
| Out of Registered, Girls Received Clinical Services | ||||||||||
| Out of Registered, Boys Received Clinical Services | ||||||||||
| Out of Registered, Girls Received Counselling | ||||||||||
| Out of Registered, Boys Received Counselling | ||||||||||
| Directly Observed Treatment, Short-Course (DOTS) | ||||||||||
| Number of on-going DOTS patients Registered | ||||||||||
| Number of DOTS Cases completed successfully | ||||||||||
| Patient Services | ||||||||||
| Outpatient - Diabetes | ||||||||||
| Outpatient - Hypertension | ||||||||||
| Outpatient - Stroke (Paralysis) | ||||||||||
| Outpatient - Acute Heart Diseases | ||||||||||
| Outpatient - Mental illness | ||||||||||
| Outpatient - Epilepsy | ||||||||||
| Outpatient - Ophthalmic Related | ||||||||||
| Outpatient - Dental | ||||||||||
| Outpatient - Oncology | ||||||||||
| Allopathic- Outpatient attendance | ||||||||||
| Ayush - Outpatient attendance | ||||||||||
| Inpatient (Male) - Children < 18 years | ||||||||||
| Inpatient (Male)- Adults | ||||||||||
| Inpatient (Female) - Children < 18 years | ||||||||||
| Inpatient (Female)- Adults | ||||||||||
| Number of Left Against Medical Advice (LAMA) Cases | ||||||||||
| Inpatient - Malaria | ||||||||||
| Inpatient - Dengue | ||||||||||
| Inpatient - Typhoid | ||||||||||
| Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections | ||||||||||
| Inpatient - Tuberculosis | ||||||||||
| Inpatient - Pyrexia of unknown origin (PUO) | ||||||||||
| Inpatient - Diarrhea with dehydration | ||||||||||
| Inpatient - Hepatitis | ||||||||||
| Patients Registered at Emergency Department | ||||||||||
| Emergency - Trauma ( accident, injury, poisoning etc) | ||||||||||
| Emergency - Burn | ||||||||||
| Emergency - Obstetrics complications | ||||||||||
| Emergency - Snake Bite | ||||||||||
| Emergency - Acute Caridiac Emergencies | ||||||||||
| Emergency - CVA ( Cerebovascular Disease) | ||||||||||
| Number of Deaths occurring at Emergency Department | ||||||||||
| Operation major (General and spinal anaesthesia) | ||||||||||
| Out of Operation major, Gynecology- Hysterectomy surgeries | ||||||||||
| Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc. | ||||||||||
| Operation minor (No or local anaesthesia) | ||||||||||
| Number of Post operative Surgical Site infection | ||||||||||
| Number of Blood units issued | ||||||||||
| Number of Blood transfusions done | ||||||||||
| Inpatient Deaths - Male | ||||||||||
| Inpatient Deaths - Female | ||||||||||
| In-Patient Head Count at midnight | ||||||||||
| Number of Admission in NBSU ( New Born Stabilisation Unit) | ||||||||||
| Special Newborn Care Unit (SNCU Admissions) - Inborn Male | ||||||||||
| Special Newborn Care Unit (SNCU Admissions) - Inborn Female | ||||||||||
| Outborn – Male | ||||||||||
| Outborn - Female | ||||||||||
| Number of Newborns Admitted in SNCU - Referred by ASHA | ||||||||||
| Number of Deaths Occurring at SNCU | ||||||||||
| Number of Children Admitted in NRC | ||||||||||
| Number of Children Discharged with Target Weight Gain from the NRCs | ||||||||||
| Number of Rogi Kalyan Samiti (RKS) meetings held | ||||||||||
| Number of Anganwadi Centres / UPHCs reported to have Conducted Village Health & Nutrition Day (VHNDs)/ Urban Health & Nutrition Day (UHNDs)/ Outreach / Special Outreach | ||||||||||
| Stock out rate of essential Drugs | ||||||||||
| Blood Units Issued on Replacement (Any Donors to be Considered as Replacement Donations) | ||||||||||
| Total Number of Blood units issued in month | ||||||||||
| Patient Satisfaction Score of the facility in Percentage (from Mera Aspatal) | ||||||||||
| Laboratory Testing | ||||||||||
| Number of Lab Tests done | ||||||||||
| Number of Hb Tests Conducted | ||||||||||
| Out of the Total Number of Hb Tests done, Number Having Hb < 7 mg | ||||||||||
| Male HIV - Number Tested (by Finger Prick Test) | ||||||||||
| Male HIV - Number Positive | ||||||||||
| Female Non ANC HIV - Number Tested (by Finger Prick Test) | ||||||||||
| Female Non ANC HIV - Number Positive | ||||||||||
| Number of Pregnant Women Screened for HIV (by Finger Prick Test) | ||||||||||
| Out of the Above, Number Screened Positive | ||||||||||
| Out of the Above, Number Screened Positive, Number confirmed with HIV infection at Integrated Counselling and Testing Centre (ICTC) | ||||||||||
| Number of Male STI/RTI Attendees Tested for Syphilis | ||||||||||
| Number of Male STI/RTI Attendees Found Sero Positive for Syphilis | ||||||||||
| Number of Female(Non ANC)STI/RTI Attendees Tested for Syphilis | ||||||||||
| Number of Female(Non ANC)STI/RTI Attendees Found Sero Positive for Syphilis | ||||||||||
| Widal Tests - Number Tested | ||||||||||
| Widal Tests - Number Positive | ||||||||||
| Radiology - X-ray | ||||||||||
| Radiology - Ultrasonography (USG) | ||||||||||
| Details of Deaths Reported with Probable Causes | ||||||||||
| Infant Deaths within 24 hours (1 to 23 hours) of birth | ||||||||||
| Infant Deaths up to 4 weeks Due to Sepsis | ||||||||||
| Infant Deaths up to 4 weeks Due to Asphyxia | ||||||||||
| Infant Deaths up to 4 weeks Due to Other Causes | ||||||||||
| Number of Infant Deaths (1 - 12 months) Due to Pneumonia | ||||||||||
| Number of Infant Deaths (1 - 12 months) Due to Diarrhoea | ||||||||||
| Number of Infant Deaths (1 - 12 months) Due to Fever related | ||||||||||
| Number of Infant Deaths (1 - 12 months) Due to Measles | ||||||||||
| Number of Infant Deaths (1 - 12 months) Due to Others | ||||||||||
| Number of Child Deaths (1 - 5 years) Due to Pneumonia | ||||||||||
| Number of Child Deaths (1 - 5 years) Due to Diarrhoea | ||||||||||
| Number of Child Deaths (1 - 5 years) Due to Fever related | ||||||||||
| Number of Child Deaths (1 - 5 years) Due to Measles | ||||||||||
| Number of Child Deaths (1 - 5 years) Due to Others | ||||||||||
| Number of Maternal Deaths Due to Bleeding | ||||||||||
| Number of Maternal Deaths Due to High fever | ||||||||||
| Number of Maternal Deaths Due to Abortion | ||||||||||
| Number of Maternal Deaths Due to Obstructed/Prolonged labour | ||||||||||
| Number of Maternal Deaths Due to Severe Hypertension/fits | ||||||||||
| Number of Maternal Deaths Due to Other Causes (including Causes not Known) | ||||||||||
| Total Facility Based Maternal Death Reviews (FBMDR) done | ||||||||||
| Number of Adolscent / Adult Deaths Due to Diarrhoeal Diseases | ||||||||||
| Number of Adolscent / Adult Deaths Due to Tuberculosis | ||||||||||
| Number of Adolscent / Adult Deaths Due to Respiratory Diseases including infections (other than TB) | ||||||||||
| Number of Adolscent / Adult Deaths Due to Other Fever Related | ||||||||||
| Number of Adolscent / Adult Deaths Due to HIV/AIDS | ||||||||||
| Number of Adolscent / Adult Deaths Due to Heart Disease/Hypertension related | ||||||||||
| Number of Adolscent / Adult Deaths Due to Cancer | ||||||||||
| Number of Adolscent / Adult Deaths Due to Neurological Disease including strokes | ||||||||||
| Number of Adolscent / Adult Deaths Due to Accidents/Burn Cases | ||||||||||
| Number of Adolscent / Adult Deaths Due to Suicide | ||||||||||
| Number of Adolscent / Adult Deaths Due to Animal bites and stings | ||||||||||
| Number of Adolscent / Adult Deaths Due to Known Acute Disease | ||||||||||
| Number of Adolscent / Adult Deaths Due to Known Chronic Disease | ||||||||||
| Number of Adolscent / Adult Deaths Due to Causes not Known | ||||||||||
| Number of Deaths Due to Malaria- Plasmodium Vivax | ||||||||||
| Number of Deaths Due to Malaria- Plasmodium Falciparum | ||||||||||
| Number of Deaths Due to Kala Azar | ||||||||||
| Number of Deaths Due to Dengue | ||||||||||
| Number of Deaths Due to Acute Encephelitis Syndrome (AES) | ||||||||||
| Number of Deaths Due to Japanese Encephalitis (JE) | ||||||||||
| Vaccines | ||||||||||
| Vaccine - Diphtheria, Pertussis and Tetanus (DPT) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Vaccine - Pentavalent | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Vaccine - Oral Polio Vaccine (OPV) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Vaccine - Tetanus Toxoid (TT) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Vaccine - Diphtheria Tetanus (DT) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Vaccine - Bacillus Calmette Guerin (BCG) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Vaccine - Measles | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Vaccine - Japanese Encephalitis (JE) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Vaccine - Hepatitis B | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Vaccine - Typhoid | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Vaccine - Vitamin K | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Rotavirus | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Inactivated Polio Vaccine | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Measles Rubella (MR) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Family Planning | ||||||||||
| Intra Uterine Devices (IUD) 380 A | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| IUD 375 A | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Condoms | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Oral Contraceptive | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Emergency Contraceptive Pills | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Centchroman Weekly Pills | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Injectable Contraceptive MPA (Vials) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Tubal Rings | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Pregnanct Testing Kits (Nischay Kits) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Other Items | ||||||||||
| Gloves | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| MVA Syringes | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Tab. Fluconazole | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Blood Transfusion Sets | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Gluteraldehyde 2% | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| IFA Tablets (Adult) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| IFA - Blue (Adolescent 10-19 years) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| IFA- Pink (Junior 6-10 years) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| IFA Syrup (Paediatric) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Paediatrics Antibiotics ( Amoxycillin and Injectable Gentamicin) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Vit A Syrup | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| ORS (New WHO) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| RTI /STI Colour Coded Syndromic Kits (I to VII) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Zinc 20 mg Tablet | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Albendazole 400 mg Tablet | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Calcium Tablets | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Syringes | ||||||||||
| Syringes - 0.1 ml (AD) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Syringes - 0.5 ml (AD) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Syringes - 5.0 ml (Disposable) | ||||||||||
| 1. Balance From Previous Month | ||||||||||
| 2. Stocks Received | ||||||||||
| 3. Unusable Stock | ||||||||||
| 4. Stock Distributed | ||||||||||
| 5. Total Stock | ||||||||||
| Rashtriya Bal Swasthaya Karyakram (RBSK) | ||||||||||
| Number of newborn Screened for defects at birth (as per RBSK) | ||||||||||
| Number of Children (6 month to 6 years) Screened by RBSK Mobile Health teams at Anganwadi center | ||||||||||
| Number of Children (6 years to 18 years) Screened by RBSK Mobile Health teams at Govt and Govt aided Schools | ||||||||||
| Number of Male Children Identified with Disease | ||||||||||
| Number of Female Children Identified with Disease | ||||||||||
| Number of Male Children Identified with Deficiency | ||||||||||
| Number of Female Children Identified with Deficiency | ||||||||||
| Number of Male Children Identified with Developmental delay | ||||||||||
| Number of Female Children Identified with Developmental delay | ||||||||||
| Number of Children Managed by Intervention - Medical | ||||||||||
| Number of Children Managed by Intervention - Surgical | ||||||||||
| Early intervention at DEIC ( District Early Intervention Centre) | ||||||||||
| Adolscent Health | ||||||||||
| Girls (6th - 12th class) Provided 4 IFA Tablets in Schools | ||||||||||
| Boys (6th - 12th class) Provided 4 IFA Tablets in Schools | ||||||||||
| Girls (6th - 12th class) Provided Albendazole in Schools | ||||||||||
| Boys (6th - 12th class) Provided Albendazole in Schools | ||||||||||
| Number of out of School Adolscent girls (10-19 years) Provided 4 IFA Tablets at Anganwadi Centres | ||||||||||
| Number of out of School Adolscent girls (10-19 years) Provided Albendazole at Anganwadi Centres | ||||||||||
| Number of adolescent girls Provided Sanitary napkin packs | ||||||||||
| Number of Sanitary napkin packs sold to adolescent girls | ||||||||||
| Number of Sanitary napkin packs distributed free to ASHA | ||||||||||
| Number of adolescent girls attended monthly meeting | ||||||||||
| Number of Children covered under WIFS JUNIOR (6 - 10 years ) Provided 4-5 IFA Tablets in Schools | ||||||||||
| Number of Children (6 - 10 years) Provided Albendazole in Schools | ||||||||||
| Number of out of School Children (6-10 years) given 4-5 IFA Tablets at Anganwadi Centres | ||||||||||
| Number of out of School Children (6-10 years) Provided Albendazole at Anganwadi Centres | ||||||||||
| Total Maternal Deaths Reviewed (MDR) by CMO | ||||||||||
| Total Maternal Deaths Reviewed (MDR) by DM | ||||||||||
| Number of maternal Deaths reported through Community Based Maternal Death Review (CBMDR) | ||||||||||
| Janani Shishu Suraksha Karyakram (JSSK) | ||||||||||
| Number of Pregnant Women Provided - Free Medicines under JSSK | ||||||||||
| Number of Pregnant Women Provided - Free Diet under JSSK | ||||||||||
| Number of Pregnant Women Provided - Free Diagnostics under JSSK | ||||||||||
| Number of Pregnant Women Provided - Free Home to facility transport under JSSK | ||||||||||
| Number of Pregnant Women Provided - Interfacility transfers when needed under JSSK | ||||||||||
| Number of Pregnant Women Provided - Free Drop Back home under JSSK | ||||||||||
| Number of sick infants Provided - Free Medicines under JSSK | ||||||||||
| Number of sick infants Provided - Free Diagnostics under JSSK | ||||||||||
| Number of sick infants Provided - Free Home to facility transport under JSSK | ||||||||||
| Number of sick infants Provided - Interfacility transfers when needed under JSSK | ||||||||||
| Number of sick infants Provided - Free Drop Back home under JSSK | ||||||||||
